# Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients

> **NCT05936606** · NA · RECRUITING · sponsor: **Yonsei University** · enrollment: 3434 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Clopidogrel monotherapy
- **DRUG:** Tailored anti-platelet therapy

## Key facts

- **NCT ID:** NCT05936606
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-16
- **Primary completion:** 2027-05
- **Final completion:** 2029-05
- **Target enrollment:** 3434 (ESTIMATED)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05936606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05936606, "Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05936606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*